Search the webpage

Created by Leona Damalakienė on  September 17, 2019  in category: News

A chance for ESTP 2019 participants!

Experimentica's partner Aiforia Technologies Oy will present joint poster dedicated for illustration of the effectivity of Aflibercept, administered systemically and for initial demonstration of convolutional neural network trained to recognize and quantify choroidal neovascularization lesion using Aiforia® Cloud.

The poster will be presented during 17-19th of September, 2019 in 17th European Congress of Toxicologic Pathology, Cologne, Germany.



Meet us at SMi’s Ophthalmic Drugs Conference 2019 in London, UK, 2019

We are pleased to be a part of the 3rd Annual Ophthalmic Drugs Conference and Focus Day, taking place on ... Read More

Experimentica Ltd. is a member of BioMelbourne Network

We are delighted to become a member of BioMelbourne Network together with other committed organisations engaged in biotechnology, medical technology, ... Read More

Let’s meet at Global Biotech VIP Week in Melbourne, 2019

Experimentica’s CEO Giedrius Kalesnykas attends Global Biotech VIP Week in Melbourne, Australia, sponsored by Global Victoria, and participates in AusBiotech ... Read More

Subscribe to Our Newsletter!

We promise that no sales pitches will be attached to newsletter. And don't worry, we hate spammers too!